Research article · 17 Jul 2026
Conference abstractPublished 25 Sep 2014
Greening the pharmaceutical industry to afford Good Laboratory Practice
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Greening the Pharmaceutical Industry to Afford Good Laboratory Practice: Discovery and application of new chemistry/ technology leading to prevention/reduction of environmental, health and safety impacts at source. Green Chemistry dates to the Pollution Prevention Act of 1990 that states the first choice for preventing pollution is to design industrial processes that do not lead to waste production. In 1993, the program was expanded to include greener solvents and safer chemicals. Recently, energy sparing chemistry in order to increase energy efficiency begins to use microwave techniques. The wellknown 12 principles of green chemistry provide both a strategy for developing safer products and the normative standards for distinguishing desirable outcomes from less desirable ones. Ibuprofen is a case study in greening the pharmaceutical industry. BHC Company was formed to develop a new green synthesis of ibuprofen from the same starting materials in fewer steps. Several studies identified six key tools for designing greener chemicals/processes which are: ? Alternative feedstocks/starting materials (raw materials) ? Alternative reagents (substances added to bring about a chemical reaction) ? Alternative solvents (substance in which other substances are dissolved) ? Alternative product/target molecule (molecule on which research is focused) ? Alternative catalysts (reusable reagents that are not consumed during the chemical reaction) ? Finally, there is a correlation through process analytical chemistry (real time measurements of manufacturing processes for production and quality control) Chemists must place a major focus on the environmental consequences of greening pharmaceutical products and the processes by which these products are made. We must consider our chemical ecological footprint.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.
More from this journal
The newest in Journal of Developing Drugs.
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Salwa Elmeligie”
